DecisionDx®-SCC
Clinical Evidence

DecisionDx-SCC is validated to predict metastatic risk for individual SCC patients with one or more risk factors. It provides unique information for squamous cell skin cancer. Incorporation of risk factors with DecisionDx-SCC test results provides superior risk assessment to either approach alone. DecisionDx-SCC can complement current cancer risk factor staging systems for patients with high-risk SCC.

0

Four published studies

0

Squamous cell skin cancer patients with one or more risk factors

0

Medical centers across the United States
Dx-SCC (1)

Metastasis-free survival validated predictor

DecisionDx-SCC May Be Right for You

Talk to your healthcare provider and healthcare team to learn more about how DecisionDx-SCC test results can be used to help better assess the risk of your cancer spreading and enable you to personalize your treatment and ongoing management.

Learn How Genomic Testing Can Help Determine Your Personalized Risk

What’s Next?

What Is the Testing Process?

How Do You Get a
DecisionDx-SCC Test?